New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an increased risk of cardiovascular (CV) disease. Despite the excellent results achieved from statin and non-statin...
Enregistré dans:
Auteurs principaux: | Alberto J Lorenzatti, Peter P Toth |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a811fc3ce3924d8caabd2cbb418db7ca |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
par: Anandita Agarwala, et autres
Publié: (2020) -
Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project
par: Ricardo Lopez Santi, et autres
Publié: (2021) -
Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
par: Alberto J Lorenzatti
Publié: (2021) -
Inflammation and Cardiovascular Disease: The Future
par: Natalie Arnold, et autres
Publié: (2021) -
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
par: Maki Komiyama, et autres
Publié: (2021)